We therefore performed screening of lymphoma tissue microarrays (Biomax) to validate the expression of metabolic markers GLUT1, Cyt-C and HK2 in human DLBCL patient samples and explore their prognostic importance. The gene discussed is HK2; the disease is diffuse large B-cell lymphoma.